These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Bjørnland K, Winberg JO, Odegaard OT, Hovig E, Loennechen T, Aasen AO, Fodstad O, Maelandsmo GM. Cancer Res; 1999 Sep 15; 59(18):4702-8. PubMed ID: 10493528 [Abstract] [Full Text] [Related]
3. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Zhang J, Zhang DL, Jiao XL, Dong Q. Eur Rev Med Pharmacol Sci; 2013 Sep 15; 17(17):2372-82. PubMed ID: 24065232 [Abstract] [Full Text] [Related]
4. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9. Saleem M, Kweon MH, Johnson JJ, Adhami VM, Elcheva I, Khan N, Bin Hafeez B, Bhat KM, Sarfaraz S, Reagan-Shaw S, Spiegelman VS, Setaluri V, Mukhtar H. Proc Natl Acad Sci U S A; 2006 Oct 03; 103(40):14825-30. PubMed ID: 16990429 [Abstract] [Full Text] [Related]
5. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. Sack U, Walther W, Scudiero D, Selby M, Kobelt D, Lemm M, Fichtner I, Schlag PM, Shoemaker RH, Stein U. J Natl Cancer Inst; 2011 Jul 06; 103(13):1018-36. PubMed ID: 21685359 [Abstract] [Full Text] [Related]
6. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. Yang XC, Wang X, Luo L, Dong DH, Yu QC, Wang XS, Zhao K. Eur Rev Med Pharmacol Sci; 2013 Jun 06; 17(12):1669-80. PubMed ID: 23832737 [Abstract] [Full Text] [Related]
7. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells. Bjørnland K, Bratland A, Rugnes E, Pettersen S, Johansen HT, Aasen AO, Fodstad Ø, Ree AH, Maelandsmo GM. J Pediatr Surg; 2001 Jul 06; 36(7):1040-4. PubMed ID: 11431772 [Abstract] [Full Text] [Related]
8. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. Jia W, Gao XJ, Zhang ZD, Yang ZX, Zhang G. Eur Rev Med Pharmacol Sci; 2013 Jun 06; 17(11):1495-508. PubMed ID: 23771538 [Abstract] [Full Text] [Related]
9. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. Zhang G, Li M, Jin J, Bai Y, Yang C. Asian Pac J Cancer Prev; 2011 Jun 06; 12(8):2075-80. PubMed ID: 22292654 [Abstract] [Full Text] [Related]
10. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. Ma X, Yang Y, Wang Y, An G, Lv G. Cancer Lett; 2010 Dec 28; 299(2):171-81. PubMed ID: 20855150 [Abstract] [Full Text] [Related]
11. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis. Berge G, Pettersen S, Grotterød I, Bettum IJ, Boye K, Mælandsmo GM. Int J Cancer; 2011 Aug 15; 129(4):780-90. PubMed ID: 20957651 [Abstract] [Full Text] [Related]
12. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma. Liu J, Guo Y, Fu S, Yang M, Sun KL, Fu WN. Oncol Rep; 2010 Apr 15; 23(4):1101-7. PubMed ID: 20204297 [Abstract] [Full Text] [Related]
13. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal. Zhang W, Liu Y, Wang CW. Eur Rev Med Pharmacol Sci; 2014 Apr 15; 18(9):1361-7. PubMed ID: 24867514 [Abstract] [Full Text] [Related]
14. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression. Kohya N, Kitajima Y, Jiao W, Miyazaki K. Int J Cancer; 2003 Mar 10; 104(1):44-53. PubMed ID: 12532418 [Abstract] [Full Text] [Related]
15. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells. Yu LJ, Li Y, Li C, Li H, Wu ML, Liu ZL, Kong QY, Chen XY, Liu XY, An LJ, Liu J. Cancer Biomark; 2014 Mar 10; 14(5):325-33. PubMed ID: 25171474 [Abstract] [Full Text] [Related]
16. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro. Cui JF, Liu YK, Zhang LJ, Shen HL, Song HY, Dai Z, Yu YL, Zhang Y, Sun RX, Chen J, Tang ZY, Yang PY. Proteomics; 2006 Nov 10; 6(22):5953-61. PubMed ID: 17051636 [Abstract] [Full Text] [Related]
17. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer. Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, Schlag PM, Shoemaker RH. Gastroenterology; 2006 Nov 10; 131(5):1486-500. PubMed ID: 17101323 [Abstract] [Full Text] [Related]
18. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells. Takenaga K, Nakamura Y, Sakiyama S. Oncogene; 1997 Jan 23; 14(3):331-7. PubMed ID: 9018119 [Abstract] [Full Text] [Related]
19. Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells. Takenaga K. Br J Cancer; 1999 Apr 23; 80(1-2):127-32. PubMed ID: 10389988 [Abstract] [Full Text] [Related]
20. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness. Matsuura I, Lai CY, Chiang KN. Biochem J; 2010 Feb 24; 426(3):327-35. PubMed ID: 20070253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]